Toward development of a precision medicine framework for metastatic, castration-resistant
prostate cancer (mCRPC), we established a multi-institutional clinical sequencing …

Heterogeneity in the genomic landscape of metastatic prostate cancer has become apparent
through several comprehensive profiling efforts, but little is known about the impact of this …

On July 31, 2013, the Prostate Cancer Foundation assembled a working committee on the
molecular biology and pathologic classification of neuroendocrine (NE) differentiation in …

The transition from castration-resistant prostate adenocarcinoma (CRPC) to neuroendocrine
prostate cancer (NEPC) has emerged as an important mechanism of treatment resistance. …

Purpose: Multiphoton-based intravital imaging has shown that invasive carcinoma cells in
mouse and rat mammary tumors intravasate when associated with perivascular macrophages, …

Importance Understanding molecular mechanisms of response and resistance to anticancer
therapies requires prospective patient follow-up and clinical and functional validation of …

Animal models, particularly mouse models, play a central role in the study of the etiology,
prevention, and treatment of human prostate cancer. While tissue culture models are extremely …

… Laboratory Medicine and Urology, Weill Cornell Medicine, New York, New York (Khani,
Robinson) … Osunkoya, Anil Parwani, Brian D. Robinson, Mark A. Rubin, Rajal B. Shah, Jeffrey S. …

Neuroendocrine prostate cancer (NEPC), also referred to as anaplastic prostate cancer, is a
lethal tumor that most commonly arises in late stages of prostate adenocarcinoma (PCA) …

Bladder cancer is approximately three times more common in men as compared to women.
We and others have previously investigated the contribution of androgens and the androgen …